SITE RESERVED FOR PROFESSIONALS
Level 2 · Controlled trialRandomised controlled trial
Supplementation with L-arginine favorably influences plasminogen activator inhibitor type 1 concentration in obese patients. A randomized, double blind trial
Bogdanski P, Szulinska M, Suliburska J, Pupek-Musialik D, Jablecka A, Witmanowski H
Journal of endocrinological investigation · 25 June 2012
AUTHORS’ ABSTRACT
The abstract of this article is not reproduced here: its licence does not allow it. It can be read freely on the journal’s website or on Europe PMC.
Scientific information content; it does not replace the advice of a healthcare professional. The presence of a study in this library does not constitute a claim about our products.
← All studies